Claims for Patent: 7,998,953

Summary for Patent: 7,998,953

Title:	Use of inhibitors of the renin-angiotensin system
Abstract:	It has been found that inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia or impaired metabolic function or efficiency. In particular, they may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and are thus useful in treatment of the symptoms and signs of aging. These inhibitors may also be used to enhance function in healthy subjects.
Inventor(s):	Montgomery; Hugh Edward (London, GB), Martin; John Francis (London, GB), Erusalimsky; Jorge Daniel (London, GB)
Assignee:	Ark Therapeutics Group, p.l.c. (London, GB)
Application Number:	11/119,181
Patent Claims:	1. A method to limit cardiac tissue damage in the event of a heart attack, wherein said method comprises administering telmisartan in a regular dose about every day for at least about 90 days to a normotensive human patient in need of such treatment. 2. The method of claim 1, wherein said patient is male.